Skip to main content

Table 3 Factors associated with 1,25-hydroxyvitamin D and 25-hydroxyvitamin D in tuberculosis patients and control subjects

From: Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study

 

25-hydroxyvitamin D

 

1,25-hydroxyvitamin D

 
 

Univariable analyses

Multivariable analyses

Univariable analyses

Multivariable analyses

 

β coefficient

P value

β coefficient

P value

β coefficient

P value

β coefficient

P value

Tuberculosis

 Sex (0 = female, 1 = male)

14.65

<0.001

−12.80

0.007

25.85

0.064

−34.37

0.057

 Age

0.41

0.001

0.32

0.024

−0.98

0.055

−1.83

0.001

 BMI

0.31

0.561

-

-

−3.59

0.111

-

-

 Smoking (0 = no, 1 = yes)

12.91

<0.001

4.84

0.062

5.13

0.711

−7.66

0.468

 Albumin

0.86

0.057

0.46

0.356

−4.14

0.018

−4.52

0.021

 VDBP

0.04

0.023

0.03

0.037

0.00

0.943

0.00

0.514

 X-ray severity score

−0.09

0.125

−0.11

0.054

0.97

<0.001

0.68

0.003

Controls

 Sex (0 = female, 1 = male)

13.92

0.001

−8.64

0.077

1.00

0.744

−35.40

0.23

 Age

0.42

0.012

0.04

0.045

−1.14

0.062

−1.69

0.08

 BMI

−0.21

0.637

-

-

−1.40

0.453

-

-

 Smoking (0 = no, 1 = yes)

12.15

0.009

3.19

0.471

1.00

0.497

2.40

0.92

 Albumin

0.57

0.424

0.13

0.858

0.55

0.885

−3.92

0.35

 VDBP

0.03

0.175

0.00

0.778

0.07

0.389

0.00

0.17

  1. P values ≤0.05 shown in bold
  2. Multivariable models include sex, age, smoking, albumin, VDBP and for TB patients, x-ray score
  3. A transformation was applied to achieve a normal distribution for VDBP (square root)